Auris Medical Provides Business Update and Reports First Half 2019 Financial Results
15 août 2019 07h00 HE
|
Auris Medical AG
Hamilton, Bermuda, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Enrollment of first patient in TRAVERS Phase 2 trial with AM-125 in acute vertigoEnrollment completed in Phase 1b trial with AM-201 in...
Wereldhave: PRESS RELEASE RESULTS FIRST HALF 2019
26 juil. 2019 01h09 HE
|
Wereldhave N.V.
Direct result € 65.8m (H1 2018: € 59.7 from continuing operations) EPRA EPS € 1.44 (H1 2018: € 1.33 from continuing operations) Netherlands and Belgium solid performance, France challenging ...